These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34683914)

  • 1. Functionalizing Ferritin Nanoparticles for Vaccine Development.
    Rodrigues MQ; Alves PM; Roldão A
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development.
    Reutovich AA; Srivastava AK; Arosio P; Bou-Abdallah F
    Biochim Biophys Acta Gen Subj; 2023 Mar; 1867(3):130288. PubMed ID: 36470367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development.
    Weidenbacher P; Musunuri S; Powell AE; Tang S; Do J; Sanyal M; Kim PS
    Biochemistry; 2023 Jan; 62(2):292-299. PubMed ID: 35960597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles.
    Kim YS; Son A; Kim J; Kwon SB; Kim MH; Kim P; Kim J; Byun YH; Sung J; Lee J; Yu JE; Park C; Kim YS; Cho NH; Chang J; Seong BL
    Front Immunol; 2018; 9():1093. PubMed ID: 29868035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
    Houser KV; Chen GL; Carter C; Crank MC; Nguyen TA; Burgos Florez MC; Berkowitz NM; Mendoza F; Hendel CS; Gordon IJ; Coates EE; Vazquez S; Stein J; Case CL; Lawlor H; Carlton K; Gaudinski MR; Strom L; Hofstetter AR; Liang CJ; Narpala S; Hatcher C; Gillespie RA; Creanga A; Kanekiyo M; Raab JE; Andrews SF; Zhang Y; Yang ES; Wang L; Leung K; Kong WP; Freyn AW; Nachbagauer R; Palese P; Bailer RT; McDermott AB; Koup RA; Gall JG; Arnold F; Mascola JR; Graham BS; Ledgerwood JE;
    Nat Med; 2022 Feb; 28(2):383-391. PubMed ID: 35115706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and Vaccine Efficacy Boosted by Engineering Human Heavy Chain Ferritin and Chimeric Hepatitis B Virus Core Nanoparticles.
    Qu Y; Zhang B; Wang Y; Yin S; Sun Y; Middelberg A; Bi J
    ACS Appl Bio Mater; 2021 Sep; 4(9):7147-7156. PubMed ID: 35006946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion.
    Cappelli L; Cinelli P; Giusti F; Ferlenghi I; Utrio-Lanfaloni S; Wahome N; Bottomley MJ; Maione D; Cozzi R
    PLoS One; 2022; 17(9):e0273322. PubMed ID: 36112575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses.
    Vu MN; Pilkington EH; Lee WS; Tan HX; Davis TP; Truong NP; Kent SJ; Wheatley AK
    Adv Healthc Mater; 2023 Jul; 12(17):e2202595. PubMed ID: 36786027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles.
    Yang F; Mariz FC; Zhao X; Spagnoli G; Ottonello S; Müller M
    Front Immunol; 2020; 11():606569. PubMed ID: 33343580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine.
    Masoomi Nomandan SZ; Azimzadeh Irani M; Hosseini SM
    Front Mol Biosci; 2022; 9():976490. PubMed ID: 36148012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity study of engineered ferritins with C- and N-terminus insertion of Epstein-Barr nuclear antigen 1 epitope.
    Qu Y; Zhang B; Wang Y; Yin S; Pederick JL; Bruning JB; Sun Y; Middelberg A; Bi J
    Vaccine; 2021 Aug; 39(34):4830-4841. PubMed ID: 34284876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
    Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
    Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice.
    Powell AE; Zhang K; Sanyal M; Tang S; Weidenbacher PA; Li S; Pham TD; Pak JE; Chiu W; Kim PS
    ACS Cent Sci; 2021 Jan; 7(1):183-199. PubMed ID: 33527087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice.
    Powell AE; Zhang K; Sanyal M; Tang S; Weidenbacher PA; Li S; Pham TD; Pak JE; Chiu W; Kim PS
    bioRxiv; 2020 Aug; ():. PubMed ID: 32869030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Application of Synthetic Affinity Ligands for the Purification of Ferritin-Based Influenza Antigens.
    Jacob SI; Khogeer B; Bampos N; Sheppard T; Schwartz R; Lowe CR
    Bioconjug Chem; 2017 Jul; 28(7):1931-1943. PubMed ID: 28558204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Ferritin-Based Platforms for Tumor Immunotherapy.
    Xu X; Tian K; Lou X; Du Y
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.